13F filing recap · Q1 2025
What did Hillman Capital Management buy in Q1 2025?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Hillman account, including accounts that belong to no fund below.
Stock value
$203.25M
Positions
51
Estimated turnover
40.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Hillman Capital Management opened positions in Hershey, Advanced Micro Devices, and Medtronic, while exiting Amazon, Home Depot, Intel, and several ETFs. The firm substantially trimmed AT&T, Verizon, Walt Disney, and Bristol-Myers Squibb, and moderately reduced Warner Bros. Discovery, CVS Health, Zimmer Biomet, and Boeing. It sharply increased Constellation Brands and Microchip Technology, and added to Brown-Forman.